Filana Therapeutics, Inc.
Support and Resistance Levels
Past performance
News About FLNA
All events for FLNA
All deals for FLNA
Financial Ratios
Financial Statements
FLNA vs Sector & Peers
About Filana Therapeutics, Inc.
Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas. Website filanatx.com
Headquarters Austin, TX, US